Sebastián Gutiérrez-Hincapié

Sebastián Gutiérrez-Hincapié

Auto-generated profile, based on publicly available information

Sebastián Gutiérrez-Hincapié

Grupo de Inmunodeficiencias Primarias, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2024 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
CECatalina Marín Echeverri
Catalina Marín Echeverri
LPLizet Pérez-Zapata
Lizet Pérez-Zapata
LÁLaura Álvarez-Acevedo
Laura Álvarez-Acevedo
SGSebastián Gutiérrez-Hincapié
Sebastián Gutiérrez-Hincapié
MAMelissa Adams-Parra
Melissa Adams-Parra
HAHeiddy del Valle Arrieta
Heiddy del Valle Arrieta

24 September 2019 in Colombia Medica
Verified
Journal Article
Open access
PDF file
CMCatalina Martinez-Jaramillo
Catalina Martinez-Jaramillo
SGSebastian Gutierrez-Hincapie
Sebastian Gutierrez-Hincapie
JAJulio César Orrego Arango
Julio César Orrego Arango
GVGloria María Vazuez-Duque
Gloria María Vazuez-Duque
RERuth María Erazo-Garnica
Ruth María Erazo-Garnica
CTClaudia Milena Trujillo-Vargas
Claudia Milena Trujillo-Vargas
Background: LPS-responsive beige -like anchor protein (LRBA) deficiency is a primary immunodeficiency disease caused by loss of LRBA protein expression, due to biallelic mutations in LRBA gene. LRBA deficiency patients exhibit a clinically heterogeneous syndrome. The main clinical complication of LRBA deficiency is immune dysregulation. Furthermore, hypogammaglobulinemia is found in more than half of patients with LRBA-deficiency. To date, no patients with this condition have been reported in Colombia Objective: To evaluate the expression of the LRBA protein in patients from Colombia with clinical phenotype associated to LRBA-deficiency. Methods: In the present study the LRBA-expression in patients from Colombia with clinical phenotype associated to LRBA-deficiency was evaluated. After then, the clinical, the immunological characteristics and the possible genetic variants in LRBA or other genes associated with the immune system in patients that exhibit decrease protein expression was evaluated. Results: In total, 112 patients with different clinical manifestations associated to the clinical LRBA phenotype were evaluated. The LRBA expression varies greatly between different healthy donors and patients. Despite the great variability in the LRBA expression, six patients with a decrease in LRBA protein expression were observed. However, no pathogenic or possible pathogenic biallelic variants in LRBA, or in genes related with the immune system were found. Conclusion: LRBA expression varies greatly between different healthy donors and patients. Reduction LRBA-expression in 6 patients without homozygous mutations in LRBA or in associated genes with the immune system was observed. These results suggest the other genetic, epigenetic or environmental mechanisms, that might be regulated the LRBA-expression.

23 December 2024 in Biomédica
Verified
Journal Article
Open access
PDF file
SGSebastián Gutiérrez-Hincapié
Sebastián Gutiérrez-Hincapié
CMCarlos Muskus
Carlos Muskus
ISIsaura Pilar Sánchez
Isaura Pilar Sánchez
JFJosé Luis Franco-Restrepo
José Luis Franco-Restrepo
CTClaudia M. Trujillo-Vargas
Claudia M. Trujillo-Vargas
Introducción. La detección temprana de linfopenias congénitas facilitaría su tratamiento oportuno y la prevención de complicaciones serias, y optimizaría los recursos del sistema de salud.Objetivo. Realizar un estudio piloto para el tamizaje neonatal de linfopenias mediante la cuantificación de los círculos de escisión (TREC y KREC) de los receptores de los linfocitos T y B en muestras de sangre periférica de neonatos de Medellín, Colombia.Materiales y métodos. Se recolectaron muestras de 1.092 neonatos y de seis pacientes con sospecha de linfopenia, mediante pinchazo del talón o del dedo gordo del pie. Se extrajo el ADN y se midieron los niveles de TREC y KREC por qPCR. Resultados. En los seis pacientes con sospecha de linfopenia se encontraron niveles muy bajos o indetectables de TREC. Todos los neonatos tamizados presentaron niveles normales de TREC y KREC. Se observó concordancia entre los valores de TREC o de KREC en dos tipos diferentes de papel de filtro. Los niveles de TREC y KREC disminuyeron considerablemente después de 24 semanas de almacenamiento de las muestras de sangre en papel de filtro. Se encontró una asociación positiva entre los niveles de los TREC y el peso al nacer, y una correlación negativa entre los KREC y la edad gestacional. Los niveles de estos marcadores no se asociaron con el tipo de parto.Conclusiones. Se presenta el primer estudio piloto para el tamizaje temprano de linfopenias congénitas en neonatos en Colombia. Se propone el uso de un límite de detección de 119 y 69 copias/μl de sangre de TREC y KREC, respectivamente, para futuros programas de detección neonatal de linfopenias en el país.

22 June 2025 in Scandinavian Journal of Immunology
Verified
Journal Article
Closed access
JÁJesús A. Álvarez‐Álvarez
Jesús A. Álvarez‐Álvarez
EVEstefanía Vásquez‐Echeverri
Estefanía Vásquez‐Echeverri
ISIsaura P. Sánchez
Isaura P. Sánchez
SHSebastián Gutierrez Hincapié
Sebastián Gutierrez Hincapié
ADAlejandro Gallon Duque
Alejandro Gallon Duque
CTClaudia M. Trujillo‐Vargas
Claudia M. Trujillo‐Vargas

23 December 2024 in Biomédica
Verified
Journal Article
Open access
PDF file
SGSebastián Gutiérrez-Hincapié
Sebastián Gutiérrez-Hincapié
JOJulio César Orrego
Julio César Orrego
JFJosé Luis Franco
José Luis Franco
CTClaudia M. Trujillo-Vargas
Claudia M. Trujillo-Vargas
Introduction. Common variable immunodeficiency is a diagnosis of exclusion in immunodeficient patients with increased susceptibility to infections,hypogammaglobulinemia, deficient response to vaccination, or low percentages of switched memory B cells. In low- and middle-income countries, the elucidation and study of molecular defects in these patients may take decades.Objective. To elucidate the genetic defect conferring impaired immunity in a patient diagnosed with common variable immunodeficiency.Materials and methods. The clinical phenotype was extracted from the clinical records. NKG2D expression in natural killer cells was evaluated by flow cytometry. The whole exome sequencing was performed in the patient and his parents. Sanger sequencing confirmed the pathogenic variant.Results. The patient suffered from upper respiratory and urinary tract infections, autoimmune hemolytic anemia, and hepatopathy. NKG2D was decreased in the differentblood subpopulations of natural killer cells. Serologic and viral load studies for Epstein-Barr virus were positive, but no B-cell malignancies have been documented. The patient presented a nonsense variant in the exon 3 of the MAGT1 gen (c.409C>T, rs387906724) in the X chromosome, resulting in an amino acid substitution of arginine for a stop codon in the position 137 of the protein (R137X). The mother also carried the pathogenic variant in a heterozygous state.Conclusions. We report the clinical case of the first Colombian male patient with a pathogenic variant in MAGT1 associated with XMEN disease. Genetic counseling and followup are recommended for families with similar cases to allow prompt detection of new cases.